Louis Moore Bacon's RVMD Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 81,700 shares of Revolution Medicines, Inc. (RVMD) worth $15.3 M, representing 0.23% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Louis Moore Bacon has maintained a strategic position in RVMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 26,100 shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +26,100 | Add 46.94% | 81,700 | $187.28 |
| Q4 2023 | +55,600 | New Buy | 55,600 | $28.68 |
Louis Moore Bacon's Revolution Medicines Investment FAQs
Louis Moore Bacon first purchased Revolution Medicines, Inc. (RVMD) in Q4 2023, acquiring 55,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Revolution Medicines, Inc. (RVMD) for 11 quarters since Q4 2023.
Louis Moore Bacon's largest addition to Revolution Medicines, Inc. (RVMD) was in Q4 2023, adding 55,600 shares worth $1.59 M.
According to the latest 13F filing for Q2 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 81,700 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $15.3 M.
As of the Q2 2026 filing, Revolution Medicines, Inc. (RVMD) represents approximately 0.23% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Revolution Medicines, Inc. (RVMD) was 81,700 shares, as reported at the end of Q2 2026.